Get the Stockscreener App
15.15
5.17%
0.64
Quantum Biopharma Ltd stock is traded at $15.15, with a volume of 68,564.
It is up +5.17% in the last 24 hours and down -11.43% over the past month.
Quantum BioPharma Ltd is a biopharmaceutical company dedicated to building a portfolio of inventive assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, it is focused on the research and development of its lead compound, Lucid-MS. Lucid-MS is a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. The company maintains a portfolio of strategic investments through its wholly owned subsidiary, which represents loans secured by residential or commercial property.
See More
Previous Close:
$14.51
Open:
$14.43
24h Volume:
68,564
Relative Volume:
0.47
Market Cap:
$58.04M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-14.63%
1M Performance:
-11.43%
6M Performance:
+119.88%
1Y Performance:
+228.17%
1-Day Range:
$14.43
$15.52
1-Week Range:
$14.43
$18.12
52-Week Range:
$2.70
$38.25
Quantum Biopharma Ltd Stock (QNTM) Company Profile
Compare QNTM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
QNTM
Quantum Biopharma Ltd
|
15.21 | 55.38M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.60 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
472.79 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.54 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
801.70 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
331.41 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Quantum Biopharma Ltd Stock (QNTM) Latest News
Quantum-Si to Report Third Quarter 2025 Financial Results on November 5, 2025 - Investing News Network
Is Quantum BioPharma Ltd. stock supported by strong fundamentalsBreakout Watch & Risk Adjusted Swing Trade Ideas - newser.com
Will Quantum BioPharma Ltd. stock sustain high P E ratiosOil Prices & Smart Swing Trading Alerts - newser.com
Building trade automation scripts for Quantum BioPharma Ltd.Trade Ideas & Free Safe Entry Trade Signal Reports - newser.com
Real time pattern detection on Quantum BioPharma Ltd. stockMarket Trend Summary & Reliable Volume Spike Trade Alerts - newser.com
Analyzing drawdowns of Quantum BioPharma Ltd. with statistical toolsPortfolio Profit Report & Daily Chart Pattern Signal Reports - newser.com
Can Quantum BioPharma Ltd. stock beat analyst upgrades2025 Market Outlook & Verified Momentum Stock Alerts - newser.com
How to recover losses in Quantum BioPharma Ltd. stockPortfolio Profit Report & Long Hold Capital Preservation Tips - newser.com
ME Therapeutics Added to CSE25 Index - Investing News Network
How to track smart money flows in Quantum BioPharma Ltd.Fed Meeting & Weekly High Potential Stock Alerts - newser.com
Quantum Biopharma's (QNTM) Sell (E+) Rating Reaffirmed at Weiss Ratings - MarketBeat
Quantum BioPharma Ltd. Investigated for Securities Fraud ViolationsContact the DJS Law Group to Discuss Your Rights – QNTM - MarketScreener
QNTM Investors Have Opportunity to Join Quantum BioPharma Ltd. Fraud Investigation with the Schall Law Firm - The AI Journal
Quantum BioPharma offers $7 million reward for stock manipulation evidence By Investing.com - Investing.com Nigeria
Quantum BioPharma Launches $7 Million Whistleblower Program Targeting Stock Manipulation - citybuzz
About Us - FinancialContent
Quantum BioPharma (QNTM) Offers $7M for Solid Evidence of Stock Manipulation - GuruFocus
Quantum BioPharma (QNTM) Introduces $7M Whistleblower Reward Pro - GuruFocus
Quantum BioPharma Launches Whistleblower Reward Amid Stock Manipulation Lawsuit - TipRanks
Quantum BioPharma offers $7 million reward for stock manipulation evidence - Investing.com India
Quantum BioPharma Ltd. Introduces Whistleblower Policy with Up to $7 Million Reward for Reporting Stock Manipulation Evidence - Quiver Quantitative
Quantum BioPharma Pioneers Digitally Integrated Biotech Model with Neuroprotective MS Treatment - citybuzz
Quantum BioPharma: Engineering the Digital Balance Sheet in Life Sciences A Vanderbilt Report View - ACCESS Newswire
7% royalty until $250M — Quantum BioPharma secures Upstream dual listing to modernize market access - Stock Titan
From Lab Bench to Blockchain: How Biotech is Reinventing Funding - The Globe and Mail
Is Quantum BioPharma Ltd. (0K91) stock at risk of policy regulation2025 Institutional Moves & Consistent Profit Trade Alerts - newser.com
Top Cannabis Stocks To ConsiderOctober 2nd - MarketBeat
Real time alert setup for Quantum BioPharma Ltd. performanceWeekly Risk Report & Consistent Income Trade Recommendations - newser.com
Why Quantum BioPharma Ltd. stock could rally in 2025Rate Hike & Daily Stock Trend Reports - newser.com
What machine learning models say about Quantum BioPharma Ltd.2025 Market Outlook & Capital Efficient Trade Techniques - newser.com
Evaluating Quantum BioPharma Ltd. with trendline analysisEarnings Overview Summary & Long-Term Safe Investment Plans - newser.com
Cannabis Stocks To Watch TodayOctober 4th - MarketBeat
Quantum BioPharma Sets Record Date for Litigation-Linked CVR Distribution - citybuzz
Quantum BioPharma Sets Record Date for Special Dividend Linked to Litigation Proceeds - MSN
Quantum BioPharma sets October 27 record date for litigation-linked CVRs - Investing.com Nigeria
Quantum BioPharma (QNTM) Sets Record Date for Contingent Value R - GuruFocus
Quantum BioPharma sets October 27 record date for litigation-linked CVRs By Investing.com - Investing.com South Africa
Quantum BioPharma Announces the Record Date for the Distribution of a Special Dividend of Contingent Value Rights (CVRs) Tied to the Future Litigation Settlement Proceeds of its USD $700 Million+ Case - The Manila Times
Upcoming Events - FinancialContent
Combining machine learning predictions for Quantum BioPharma Ltd.July 2025 Recap & Long-Term Safe Investment Ideas - newser.com
Analyzing recovery setups for Quantum BioPharma Ltd. investorsQuarterly Portfolio Report & Consistent Return Strategy Ideas - newser.com
Quantum BioPharma receives final toxicity reports for MS drug candidate By Investing.com - Investing.com Nigeria
Quantum Biopharma Ltd Stock (QNTM) Financials Data
There is no financial data for Quantum Biopharma Ltd (QNTM). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
1.24%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):